Karmefors Idvall Moa, Tanushi Hideyuki, Berge Andreas, Nauclér Pontus, van der Werff Suzanne Desirée
Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, 171 77, Stockholm, Sweden.
Department of Data Processing and Analysis, Karolinska University Hospital, Stockholm, Sweden.
Antimicrob Resist Infect Control. 2024 Feb 5;13(1):15. doi: 10.1186/s13756-024-01373-w.
Continuous surveillance for healthcare-associated infections such as central venous catheter-related bloodstream infections (CVC-BSI) is crucial for prevention. However, traditional surveillance methods are resource-intensive and prone to bias. This study aimed to develop and validate fully-automated surveillance algorithms for CVC-BSI.
Two algorithms were developed using electronic health record data from 1000 admissions with a positive blood culture (BCx) at Karolinska University Hospital from 2017: (1) Combining microbiological findings in BCx and CVC cultures with BSI symptoms; (2) Only using microbiological findings. These algorithms were validated in 5170 potential CVC-BSI-episodes from all admissions in 2018-2019, and results extrapolated to all potential CVC-BSI-episodes within this period (n = 181,354). The reference standard was manual record review according to ECDC's definition of microbiologically confirmed CVC-BSI (CRI3-CVC).
In the potential CVC-BSI-episodes, 51 fulfilled ECDC's definition and the algorithms identified 47 and 49 episodes as CVC-BSI, respectively. Both algorithms performed well in assessing CVC-BSI. Overall, algorithm 2 performed slightly better with in the total period a sensitivity of 0.880 (95%-CI 0.783-0.959), specificity of 1.000 (95%-CI 0.999-1.000), PPV of 0.918 (95%-CI 0.833-0.981) and NPV of 1.000 (95%-CI 0.999-1.000). Incidence according to the reference and algorithm 2 was 0.33 and 0.31 per 1000 in-patient hospital-days, respectively.
Both fully-automated surveillance algorithms for CVC-BSI performed well and could effectively replace manual surveillance. The simpler algorithm, using only microbiology data, is suitable when BCx testing adheres to recommendations, otherwise the algorithm using symptom data might be required. Further validation in other settings is necessary to assess the algorithms' generalisability.
对医疗保健相关感染,如中心静脉导管相关血流感染(CVC - BSI)进行持续监测对于预防至关重要。然而,传统监测方法资源密集且容易产生偏差。本研究旨在开发并验证用于CVC - BSI的全自动监测算法。
利用卡罗林斯卡大学医院2017年1000例血培养(BCx)呈阳性的住院患者的电子健康记录数据开发了两种算法:(1)将BCx和CVC培养中的微生物学结果与BSI症状相结合;(2)仅使用微生物学结果。这些算法在2018 - 2019年所有住院患者的5170例潜在CVC - BSI事件中进行了验证,并将结果外推至该期间内所有潜在的CVC - BSI事件(n = 181,354)。参考标准是根据欧洲疾病预防控制中心(ECDC)对微生物学确诊的CVC - BSI(CRI3 - CVC)的定义进行人工记录审查。
在潜在的CVC - BSI事件中,51例符合ECDC的定义,两种算法分别将47例和49例识别为CVC - BSI。两种算法在评估CVC - BSI方面均表现良好。总体而言,算法2在整个期间表现略好,敏感性为0.880(95%置信区间0.783 - 0.959),特异性为1.000(95%置信区间0.999 - 1.000),阳性预测值为0.918(95%置信区间0.833 - 0.981),阴性预测值为1.000(95%置信区间0.999 - 1.000)。根据参考标准和算法2计算的发病率分别为每1000个住院日0.33和0.31。
两种用于CVC - BSI的全自动监测算法均表现良好,可有效替代人工监测。当BCx检测遵循建议时,仅使用微生物学数据的较简单算法适用,否则可能需要使用症状数据的算法。需要在其他环境中进一步验证以评估算法的通用性。